Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
Irene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 388-395
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Monoclonal Gammopathies
Rafael Ríos Tamayo
Elsevier eBooks (2024), pp. 358-374
Closed Access | Times Cited: 11
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10
Teresa Calimeri, Nicoletta Anzalone, Maria Giulia Cangi, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 7, pp. e540-e549
Closed Access | Times Cited: 6
Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation
Simon Østergaard, Lars Munksgaard, Troels Hammer, et al.
Annals of Hematology (2025)
Open Access
Diagnostic next-generation sequencing to detect MYD88 L265P in Lymphoplasmacytic lymphoma compared to ddPCR
Lauren M. Wainman, Guohong Huang, Donald C. Green, et al.
Experimental and Molecular Pathology (2025) Vol. 141, pp. 104956-104956
Open Access
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia
Romanos Sklavenitis‐Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Multicolor flow cytometry in the diagnosis of Waldenstrom macroglobulinemia
I. V. Galtseva, Yu. A. Tsoy, A. Grachev, et al.
Oncohematology (2025) Vol. 20, Iss. 1, pp. 128-138
Open Access
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience
Nicolò Danesin, Laura Bonaldi, Annalisa Martines, et al.
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 2961-2968
Open Access | Times Cited: 3
<i>MYD88</i> mutation-positive indolent B-cell lymphoma with CNS involvement: Bing–Neel syndrome mimickers
Kenichiro Takeda, Shoichiro Okazaki, Rintaro Minami, et al.
Journal of Clinical and Experimental Hematopathology (2024) Vol. 64, Iss. 3, pp. 252-260
Open Access | Times Cited: 2
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single‐arm FIL‐BRB trial
Giulia Benevolo, Daniela Drandi, Nicoletta Villivà, et al.
British Journal of Haematology (2024)
Closed Access | Times Cited: 2
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Falko Fend, Michiel van den Brand, Patricia J.T.A. Groenen, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 195-214
Open Access | Times Cited: 6
Highly Sensitive Detection Method of CXCR4 Tumor Hotspot Mutations by Drop-Off Droplet Digital PCR in Patients with IgM Monoclonal Gammopathies
Athina Markou, Tina Bagratuni, Christina Tsakiri, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 7, pp. 502-512
Open Access | Times Cited: 4
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study
Oihane Pérez‐Escurza, Juan Flores‐Montero, Jón Þórir Óskarsson, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice
Simon Østergaard, Lone Schejbel, Marie Fredslund Breinholt, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 6, pp. 758-767
Closed Access | Times Cited: 1
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.
Michele Bibas, Jorge J. Castillo, Shayna Sarosiek
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2023061-e2023061
Open Access | Times Cited: 1
Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia
Karima Amaador, Catherine Thiéblemont, Judith Trotman, et al.
Hematological Oncology (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 2
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level
Ramón García‐Sánz, María García‐Álvarez, Alejandro Medina, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 8
Open Access | Times Cited: 2
The performance and applied value of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Bo Pan, Xingxing Zhu, Qiang Xie
PubMed (2023) Vol. 13, Iss. 5, pp. 217-224
Closed Access | Times Cited: 2
There’s life in the old dog yet: immunochemotherapy in Waldenström’s macroglobulinemia
Efstathios Kastritis, Christian Buske
Leukemia (2024) Vol. 38, Iss. 6, pp. 1435-1436
Open Access
Impact of Chromosomal Aberrations Detected by Chromosome Banding Analysis in Symptomatic Waldenström’s Macroglobulinemia
Kenichi Ito, Tomoko Kitagawa, Kunihiko Haráda, et al.
Research Square (Research Square) (2024)
Open Access
Prognostic impact of nodal involvement in Waldenström macroglobulinaemia
Simon Østergaard, Lars Munksgaard, Troels Hammer, et al.
British Journal of Haematology (2024)
Open Access
Impact of chromosomal aberrations detected by chromosome banding analysis in symptomatic Waldenström’s macroglobulinemia
Kenichi Ito, Tomoko Kitagawa, Kunihiko Haráda, et al.
Annals of Hematology (2024)
Open Access
Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
Simon Østergaard, Lars Munksgaard, Torsten Holm Nielsen, et al.
eJHaem (2024) Vol. 5, Iss. 6, pp. 1269-1273
Open Access
Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma
Oliver Tomkins, Shirley D’Sa
Frontiers in Oncology (2024) Vol. 14
Open Access
Lymphoplasmacytic lymphoma and Waldenström Macroglobulinemia, A Decade After the Discovery of MYD88L265P
Lianqun Qiu, Pei Lin
Human Pathology (2024), pp. 105708-105708
Closed Access
CD23 expression in lymphoplasmacytic lymphoma: Clinical–pathological and biological correlations
Marco Pizzi, Nicolò Danesin, Federico Scarmozzino, et al.
Histopathology (2024)
Closed Access
Page 1 - Next Page

Scroll to top